16January

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes ... Read more

30December

Financial calendar 2020 ... Read more

19December

University of Virginia Center for Diabetes Technology and Novo Nordisk enter int ... Read more

20November

Novo Nordisk and UNICEF announce new partnership to help prevent childhood over ... Read more

20January

Novo Nordisk A/S – Share repurchase programme ... Read more

16January

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes ... Read more

13January

Novo Nordisk A/S – Share repurchase programme ... Read more

30December

Financial calendar 2020 ... Read more

05February

Financial statement for the full year of 2019,

12February

Cut-off date for shareholders' proposals in connection with the Annual General Meeting (AGM),

26March

Annual General Meeting, Copenhagen

01April

Silent period,

 

 

 

Investors

Share information
 

Capital markets day


Capital Markets Day 2019 
- Webcast and presentations

SHARE Magazine


Get the latest SHARE Magazine
- news for you as an investor

Corporate reporting

Rybelsus® US approval

 



Access conference call
- Webcast and presentation

Private shareholders


Shareholder tools and systems for private investors

 

Investor materials

Contact Investor Relations

Sign-up: Company announcements


Sign up and receive our company announcements

 

Financial results and events overview